Our Vision:
A world where every myeloma patient can live life to the fullest,
unburdened by the disease.
I am a...
About Multiple Myeloma
Multiple myeloma starts in the bone marrow plasma cells. It weakens the immune system and can affect many parts of the body by causing the bone marrow to create dysfunctional antibodies and plasma cells. Living with or treating this disease means making complicated decisions, and this requires searching for reliable, current information on multiple myeloma.
How Can the International Myeloma Foundation Help?
The International Myeloma Foundation (IMF) connects people to what matters most — research that pushes the field forward, education that clarifies complex topics, support tailored to individual needs, and advocacy that amplifies every voice. Patients, care partners, healthcare professionals, and researchers can access the knowledge, resources, and community they need from the IMF to navigate life with myeloma.
This week’s blog was written by Valarie Traynham, who was diagnosed with myeloma at age 42. Valarie talks about her myeloma journey, and the issues and challenges in healthcare that she had to face as an African American woman. Read the blog and discover how Valarie overcame the odds, and why she keeps fighting to fix the system that’s supposed to help myeloma patients heal. . READ THE BLOG.
It is with great sadness that the International Myeloma Foundation (IMF) shares the news of the death of Dr. Brian G.M. Durie, co-founder of the organization. Learn more about his legacy from this tribute page: VISIT THE TRIBUTE.
The next Las Voces de Mieloma (Spanish/virtual) Support Group will take place on Tuesday, November 18, from 10 a.m. - 11 a.m. PST. The Guest Speaker for this meeting will be Stefania Mancia, APRN, a board-certified Nurse Practitioner specializing in malignant hematology and cellular therapy. She leads the Survivorship Program at Moffitt Malignant Hematology and Cellular Therapy, Memorial Cancer Institute. Ms. Manca will discuss long-term care at this meeting. REGISTER HERE.
La próxima reunión del Grupo de Apoyo Las Voces de Mieloma (en español y virtual) se llevará a cabo el martes 18 de noviembre, de 10:00 a 11:00 a. m. (hora del Pacífico). La oradora invitada será Stefania Mancia, APRN, enfermera practicante certificada especializada en hematología maligna y terapia celular. Dirige el Programa de Supervivencia en Hematología Maligna y Terapia Celular del Instituto Oncológico Moffitt Memorial. La Sra. Mancia hablará sobre los cuidados a largo plazo. REGÍSTRATE AQUÍ.
On November 6, 2025, according to an FDA press release, "the Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) for adults with high-risk smoldering multiple myeloma (SMM)." READ THE PRESS RELEASE.
Join the IMF Virtual Myeloma Community Workshop on Monday, November 17, at 3:00 p.m. PST | 4:00 p.m. MT | 5:00 p.m. CT | 6:00 p.m. p.m. EST for expert debates on key issues in myeloma care. Hear from IMF Vice President of Patient Support Robin Tuohy and top myeloma specialists as they discuss topics like treating high-risk smoldering myeloma, using MRD to guide therapy, and CAR T-cell treatment at first relapse. The program concludes with a live panel Q&A where attendees can ask their questions directly to the experts. REGISTER NOW.
The International Myeloma Foundation (IMF) is excited to announce that an in-person Myeloma Community Workshop will take place on Saturday, November 15, 2025, at the Sheraton Raleigh (421 South Salisbury Street, Raleigh, NC 27601). Visit the following link to see which myeloma experts will present at this event: LEARN MORE.
Need assistance in creating a fundraiser? The IMF team is here for you. Find out how you can help in the fight against myeloma today!
